Skip to content

How a global biopharma company became a leader in ethical AI

Artificial Intelligence (AI) has emerged as a key agent of transformation, creating opportunities for enhanced insight and efficiency in all industries. Biopharma is no exception.

EY teams used the global Responsible AI framework to help a biopharma optimize AI governance, mitigate AI risks and protect stakeholders.

Read more HERE

Back To Top